Veona Cost Per Reportable Test (CPRT)
Know what a reportable test actually costs you. Veona consolidates consumables, reagents, QC control consumption, wastage, and overheads into one per-test cost framework, then compares expected against actual across tests, instruments, and time periods, so you find inefficiencies and price with confidence. It is built natively on Veona's stock weighted-average cost and general ledger, not a spreadsheet.
The true cost of every reportable test, in one framework.
Most laboratories price tests on a guess, because the real cost of a reportable result is scattered across reagent invoices, consumable issues, the controls a QC run burns, the wastage nobody counts, and a share of overheads. Veona Cost Per Reportable Test pulls all of it into one framework, drawing component costs straight from stock at weighted-average cost and overheads from the general ledger, so there is one defensible cost per reportable test. It then compares the expected cost against what each test actually consumed, across tests, instruments, and time periods, surfacing where money leaks and where a price no longer covers the work. The result is costing you can stand behind in a tender, a payer negotiation, or a margin review, with no spreadsheet to reconcile.
Every cost component, consolidated
A reportable test costs more than its reagent. CPRT consolidates the consumables and reagents it draws, the QC control consumption it shares, the wastage from expiry and repeats, and an allocated share of overheads into one per-test figure, so the number reflects the full cost of producing a result rather than the obvious part of it.
Native on stock WAC and the general ledger
Component costs are drawn straight from stock at weighted-average cost, the same valuation the rest of Veona posts, and overheads from the general ledger, so the cost moves the moment a reagent price or an issue does. There is no parallel spreadsheet to maintain and no reconciliation, because CPRT reads the books the hospital already runs.
Expected versus actual, with variance
Set the expected cost of a test and CPRT compares it to what each run actually consumed, flagging the variance and what drove it, an over-issue, a higher reagent price, repeats, or wastage. The leaks are named rather than guessed at, so the lab fixes the few tests that move the number instead of trimming everywhere.
Compare across instruments and time, price with confidence
Slice cost per reportable test by instrument and by period to see which analyzer runs a test cheaply, where a reagent price rise has eroded margin, and how cost trends month over month. With the true cost in hand, set or defend a price in a tender or a payer negotiation knowing the margin is real, not assumed.
Costing the lab can stand behind.
Full cost build-up
Reagents, consumables, QC, wastage, overheads.
Stock WAC
Component costs at weighted-average cost.
GL overheads
Allocated straight from the general ledger.
Expected vs actual
Variance with the driver named.
By instrument
See which analyzer runs a test cheaply.
By time period
Track cost trends month over month.
Price confidence
Set and defend prices on real margin.
Tender and payer ready
Costing you can present and defend.
No spreadsheets
Native on the books you already run.
From component costs to a defended price.
Consolidate
Reagents, QC, wastage, and overheads into one per-test cost.
Source
Components from stock WAC, overheads from the general ledger.
Compare
Expected against actual, by test, instrument, and period.
Price
Fix the driver and set a price on real margin.
Connected to the rest of Veona.
What buyers ask about Veona Cost Per Reportable Test.
What goes into the cost per reportable test?
Everything it takes to produce a result: the consumables and reagents the test draws, the QC controls it shares, the wastage from expiry and repeats, and an allocated share of overheads, consolidated into one defensible per-test figure.
Where do the numbers come from?
Component costs are drawn from Veona Stock at weighted-average cost, the same valuation the rest of the platform posts, and overheads from the Veona Finance general ledger. There is no separate spreadsheet to maintain or reconcile.
What does expected versus actual show me?
You set an expected cost per test and CPRT compares it to what each run actually consumed, flagging the variance and its driver, whether an over-issue, a reagent price rise, repeats, or wastage, so you fix the few tests that move the number.
How does it help with pricing?
By comparing cost across tests, instruments, and time periods, you see where margin has eroded and which analyzer runs a test cheaply, so you can set or defend a price in a tender or a payer negotiation knowing the margin is real.
See Veona Cost Per Reportable Test in action.
A walkthrough of the per-test cost framework, expected versus actual, built natively on stock WAC and the general ledger.